MKS Instruments stock hits 52-week high at 142.33 USD

MKS Instruments Inc stock reached a new 52-week high, hitting 142.33 USD, underscoring a significant upward trajectory over the past year. With an impressive 115% gain over the past six months and a "GOOD" Financial Health score according to InvestingPro, the company demonstrates strong momentum. This milestone reflects a robust 1-year change of 40.48%, indicating strong performance and investor confidence in the company’s prospects. The stock’s ascent to this 52-week high highlights its resilience and growth in a competitive market environment, attracting attention from both existing shareholders and potential investors. Trading at a relatively high P/E ratio of 35.5x and maintaining dividend payments for 15 consecutive years, the stock appears slightly overvalued according to InvestingPro’s Fair Value analysis. Discover 8 more exclusive ProTips and comprehensive valuation metrics with InvestingPro.

In other recent news, MKS Instruments reported its financial results for the second quarter of 2025, surpassing analysts’ expectations. The company achieved an earnings per share of $1.77, beating the forecast of $1.62, and reported revenue of $973 million, exceeding the anticipated $931.11 million. Additionally, MKS Instruments is considering selling a $1 billion specialty chemical division to concentrate more on its semiconductor manufacturing business. This potential sale aligns with KeyBanc’s continued Overweight rating and a price target of $160.00 for the company.

Needham has also raised its price target for MKS Instruments to $136.00 from $130.00, maintaining a Buy rating. The firm expects the company’s Semiconductor business to grow at low double digits in 2025 and forecasts low single-digit growth for 2026. These developments reflect a positive outlook from analysts on MKS Instruments’ strategic focus and financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.